Castle Biosciences’ DecisionDx®-Melanoma Test Receives 2022 MedTech Breakthrough Award

Go back to Castle Biosciences’ DecisionDx®-Melanoma Test Receives 2022 MedTech Breakthrough Award
Castle Technologies, Inc. (NASDAQ: CSTL) Delayed: 33.17 -0.27 (0.81%)
Previous Close $33.44    52 Week High $3.92 
Open $33.36    52 Week Low $0.00 
Day High $34.73    P/E N/A 
Day Low $32.69    EPS $0.00 
Volume 94,583